Trident Lifeline Ltd. (TLL) 52 Week High Streak: Back-to-Back Highs

Trident Lifeline Ltd. 52 Week High Streak has now stretched to its second straight session, with the stock trading within 2% of its 52-week high across the period and advancing 9.52% over the streak. On 15 October 2026 at 11:52 AM IST, the share was last traded at Rs 414 after touching a high of Rs 414. The latest Univest data confirms the price pattern, but it does not establish a company-specific catalyst for the continued move.

The share was trading above its previous close of Rs 402.25, after opening at Rs 399.65 and touching a low of Rs 399.65. Trident Lifeline Ltd. has a market capitalisation of Rs 451.97 crore, which places the repeated-high pattern in a broader context for readers: this is not just a single-day jump, but a multi-session stretch that keeps the stock near its one-year peak.

Trident Lifeline Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 414
Previous Close	Rs 402.25
Today's Move	+Rs 11.75 (+2.92%)
Open	Rs 399.65
High	Rs 414
Low	Rs 399.65
Market Capitalisation	Rs 451.97 crore

Trident Lifeline Ltd. (TLL) traded at Rs 414 versus the previous close of Rs 402.25, a rise of 2.92%. The stock opened at Rs 399.65, reached a high of Rs 414 and touched a low of Rs 399.65.

Trident Lifeline Ltd. was last traded at Rs 414, higher by Rs 11.75 or 2.92% versus the previous close of Rs 402.25. The stock opened at Rs 399.65, matched the day’s low at Rs 399.65 and touched a high of Rs 414, leaving it at the upper end of the intraday range as of 15 October 2026 at 11:52 AM IST. That movement keeps the share price near its 52-week high while the broader streak remains the more important signal than one print.

For readers tracking Trident Lifeline Ltd. Share Price Today, the immediate picture is straightforward: the stock has stayed close to its one-year peak for a second straight session and has moved 9.52% across that stretch. The market capitalisation of Rs 451.97 crore keeps the company in a size bracket where small absolute moves can still matter to market perception, but the latest session should still be read as part of the ongoing Trident Lifeline Ltd. Stock News flow rather than as a standalone event. The price action also sits inside a wider Trident Lifeline Ltd. Stock Performance discussion around repeated highs.

What the Repeated 52-Week Highs Show

Trident Lifeline Ltd. 52 Week High Streak matters because it shows persistence near the one-year peak rather than a one-off move. Across two consecutive sessions, the stock has stayed within 2% of its 52-week high and has added 9.52% over the stretch. That is the clearest numerical read from the latest Trident Lifeline Ltd. Share Price Update, and it is the key difference between a single-day high and a repeated pattern.

What the repeated highs show is that the latest market data confirms continuation, not a fresh company event. The price behaviour can remain in focus even without a confirmed catalyst, especially when a stock keeps trading close to a yearly high for multiple sessions. For those scanning Stocks Hitting 52 Week Highs or watching Stocks At One Year High Today, the important point is that the pattern itself is now established for Trident Lifeline Ltd. Consecutive 52 Week Highs often draw attention because the market keeps the share near a familiar level, but the data here supports only the pattern, not a cause.

Trident Lifeline Ltd. (TLL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 451.97 crore
P/E Ratio	25.26x
P/B Ratio	4.88x
ROE	18.78%
ROCE	19.17%
EPS	Rs 15.92
Book Value Per Share	Rs 82.4
Dividend Yield	0%

Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 25.26x, P/B 4.88x, ROE 18.78%, ROCE 19.17%. These figures provide context only and are not a buy or sell signal.

Trident Lifeline Ltd. has a market capitalisation of Rs 451.97 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.26x, P/B at 4.88x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.92, book value per share of Rs 82.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.56x, median ROE of 11.48%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.26x
Benchmark Median P/E	27.56x
Benchmark Average P/E	39.92x
Benchmark P/E Range	0x to 654.72x
Company P/B Ratio	4.88x
Benchmark Median P/B	2.8x
Company ROE	18.78%
Benchmark Median ROE	11.48%
Company ROCE	19.17%
Benchmark Median ROCE	13.28%
Company Market Capitalisation	Rs 451.97 crore
Benchmark Median Market Cap	Rs 843.36 crore

Trident Lifeline Ltd. (TLL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Trident Lifeline Ltd. (TLL) has a P/E ratio of 25.26x, which is below the benchmark median of 27.56x, a difference of -8.35%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.48%, a difference of +63.59%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.28%, a difference of +44.35%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Albert David Ltd.	ALBERTDAVD	458.83	20.33	1.08	-0.38	0.83
SMS Lifesciences India Ltd.	HALEOSLABS	467.43	29.51	2.17	8.68	10.53
Jenburkt Pharmaceuticals Ltd.	JENBURPH	403.82	12.3	1.99	18.84	25.34
Medicamen Biotech Ltd.	MEDICAMEQ	402.75	37.93	1.52	3.23	5.77
Astonea Labs Ltd.	ASTONEALAB	340.56	75.42	5.96	11.95	10.51

Trident Lifeline Ltd. (TLL) has a P/E ratio of 25.26x compared with the displayed peer median of 29.51x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 8.68% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 10.51%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 451.97 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Trident Lifeline Ltd.

• Trident Lifeline Ltd. 52 Week High Streak has now run for a second straight session.
• The stock has moved 9.52% across the streak, keeping Trident Lifeline Ltd. Stock Performance in focus.
• It was last traded at Rs 414, near its 52-week high.
• The company’s ROE and ROCE are above the industry median.
• The market capitalisation of Rs 451.97 crore keeps the share in a closely watched size range.

About Trident Lifeline Ltd.

Trident Lifeline Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s listed profile, valuation ratios and return metrics make it a stock that often enters screens for Trident Lifeline Ltd. Stock News, Trident Lifeline Ltd. Share Price and Trident Lifeline Ltd. Fundamental Analysis. Its current market capitalisation is Rs 451.97 crore, with P/E at 25.26 and P/B at 4.88.

The latest market pattern shows the share staying close to its 52-week high for a second straight session. That keeps the company in the broader group of 52 Week High Stocks and Stocks In News Today, where repeated strength near a yearly peak can remain on trader and investor watchlists without requiring a fresh corporate event.

FAQ

What does Trident Lifeline Ltd. 52 Week High Streak mean?

It means the stock has traded within 2% of its 52-week high for consecutive sessions. In this case, Trident Lifeline Ltd. has done so for a second straight session, which keeps the share near its one-year peak.

How much has Trident Lifeline Ltd. moved across the streak?

According to the latest Univest figures, Trident Lifeline Ltd. has moved 9.52% across the streak. That cumulative move is more useful than a one-session change because it captures the repeated price behaviour near the yearly high.

Is there a confirmed company-specific catalyst behind the move?

No confirmed catalyst is established by the latest market data. The pattern shows repeated trading near the 52-week high, but the figures do not identify a company-specific trigger for the continued move.

How did Trident Lifeline Ltd. trade on the latest session?

The share was last traded at Rs 414, after opening at Rs 399.65 and touching a low of Rs 399.65. It also touched a high of Rs 414, which places the stock near the top of the day’s range.

How do Trident Lifeline Ltd. valuation ratios compare with peers?

The stock’s P/E of 25.26 is below the industry median, while its P/B of 4.88 is above the industry median. That mix suggests a valuation profile that is not cheap on every measure, but is supported by stronger return ratios.

What do ROE and ROCE indicate for Trident Lifeline Ltd.?

ROE at 18.78% and ROCE at 19.17% both sit above the industry median. Those figures show better capital efficiency than many healthcare peers, which is relevant for Fundamental Analysis and stock comparison.

Why is the stock staying in focus among 52 Week High Stocks?

Repeated proximity to the one-year peak often keeps a stock on screening lists. Trident Lifeline Ltd. remains in focus because it has stayed near its 52-week high across consecutive sessions and has maintained a cumulative gain across the streak.

What should investors monitor next in Trident Lifeline Ltd.?

Investors can track whether the stock continues to trade near its 52-week high, whether the cumulative move extends further, and whether company or sector updates change the current pattern. The present data confirms the streak, not a specific catalyst.

},

Frequently Asked Questions

What is the current share price of Trident Lifeline Ltd. (TLL)?

Ans. Trident Lifeline Ltd. (TLL) last traded at Rs 414. That is against a previous close of Rs 402.25, a move of 2.92% so far today.

What is the market capitalisation of Trident Lifeline Ltd. (TLL)?

Ans. The market capitalisation of Trident Lifeline Ltd. (TLL) stands at Rs 451.97 crore. The company is classified under the Healthcare sector. Market capitalisation indicates company size and is not a measure of quality.

What are the valuation ratios of Trident Lifeline Ltd. (TLL)?

Ans. Trident Lifeline Ltd. (TLL) trades at a P/E ratio of 25.26x and a P/B ratio of 4.88x. These are valuation multiples and are not, by themselves, a buy or sell signal.

What are the return ratios of Trident Lifeline Ltd. (TLL)?

Ans. Trident Lifeline Ltd. (TLL) reports ROE of 18.78% and ROCE of 19.17%. These figures describe capital efficiency and are provided for context only.

Track Trident Lifeline Ltd. (TLL) Share Price on Univest

Use Trident Lifeline Ltd. (TLL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.